Brief: Medipal Recieves Orphan Drug Designation For JR-446 For Mucopolysaccharidosis Type IIIB
29/09/2025 18:01
Sept 29 (Reuters) - MEDIPAL: MEDIPAL - NOTICE OF ORPHAN DRUG DESIGNATION FOR JR-446 FOR MUCOPOLYSACCHARIDOSIS TYPE IIIB BY MINISTRY OF HEALTH, LABOUR AND WELFARE OF JAPAN ((Reuters.Briefs@thomsonreuters.com;))